Usona Institute Campus Information Briefing & Groundbreaking
July 29, 2021–(BUSINESS WIRE)–Usona Institute:
|
|
||
|
WHAT: |
Usona Institute, a non-profit medical research organization in Fitchburg, WI, is breaking ground on a new campus facility. The Usona Institute Campus will serve as a global center in the field of psychedelic research for the Usona team and its many collaborations with scientists, academics and clinicians worldwide. In addition to the groundbreaking, media are invited to attend an information briefing along with key researchers, policy influencers and clinicians from around the country who will discuss personal stories, emerging public policy and the status of current clinical research. |
|
|
|
||
|
WHEN: |
Tuesday, August 3, 2021 |
|
|
Ceremony & Reception – 5:00-7:00 pm |
||
|
|
||
|
WHERE: |
Information Briefing |
|
|
Kornberg Center Atrium (See Promega Campus Map) |
||
|
5430 East Cheryl Parkway |
||
|
Fitchburg, WI 53711 |
||
|
*Parking available at front entrance and shuttle will be provided to and from the ceremony site. |
||
|
Groundbreaking Ceremony & Reception |
||
|
2881 Woods Hollow Rd. |
||
|
Fitchburg, WI 53711 |
||
|
Click here for map and please follow the directional signs to the site location. The site is unpaved so please dress comfortably with appropriate shoes for uneven ground. If you need any mobility assistance, please let us know. |
||
|
|
||
|
WHY: |
Investigation of new and existing psychedelic molecules are showing therapeutic potential in the treatment of mental health conditions, including depression, anxiety, PTSD, OCD, eating disorders, cluster and migraine headaches, alcohol, nicotine and other substance use disorders. |
|
|
The hope for this work continues to grow from many years of academic research to a raised level of public awareness in the mainstream. And as new scientific studies come out, we are seeing the interest expand into public policy as referenced by the Director of NIH and a new law at the state level. Usona Institute works across the spectrum from drug discovery and clinical research to FDA approval and delivery of care.
Among its high priority areas of work, Usona is currently sponsoring a Phase 2 clinical trial in the study of psilocybin as a treatment for Major Depressive Disorder under FDA Breakthrough Therapy Designation. The study is running at multiple sites across the US including the UW Madison. |
ABOUT USONA:
Usona Institute is a non-profit medical research organization created to serve the public good with an open science model of operation. We conduct and support pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin and other consciousness-expanding medicines. Our focus is on alleviating depression and anxiety in people for whom current medical treatments fall short in offering relief and a better quality of life.
Contacts
Penny Patterson
Director, Communications
Usona Institute
608-235-3158
[email protected]